P76.43 Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLC

G. Bravo Montenegro, A. Vanderwalde,L. Raez,J. Nieva,R. Feldman,A. Herrmann,M. Nagasaka, C. Ikpeazu,H. Mamdani,S. Pai, A. Wozniak, A. Spira, G. Lopes,S. Liu,C. Kim

Journal of Thoracic Oncology（2021）

引用 1|浏览11

暂无评分

摘要

NSCLC harboring an EGFR exon 20 insertion (ex20ins) often has additional genomic aberrations, which may influence the underlying biology and predict outcomes. Clinical outcomes data overall remain limited in patients (pts) with ex20ins and comprehensive characterization of these tumors is lacking.

查看译文

关键词

egfr exon,co-occurring

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要